Xilio Therapeutics, Inc. - 10-Q Filing
Xilio Therapeutics filed a Form 10-Q for the first quarter of fiscal year ending December 31, 2026. The filing includes financial data and disclosures related to its collaboration agreements with Abbvie Group Holdings and Gilead Sciences Inc., as well as stock purchase agreements and equity compensation plans.
Tickers: $XLO